267 related articles for article (PubMed ID: 19477356)
1. Diminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular risk.
Tang WH; Wang Z; Cho L; Brennan DM; Hazen SL
J Am Coll Cardiol; 2009 Jun; 53(22):2061-7. PubMed ID: 19477356
[TBL] [Abstract][Full Text] [Related]
2. Targeted metabolomic evaluation of arginine methylation and cardiovascular risks: potential mechanisms beyond nitric oxide synthase inhibition.
Wang Z; Tang WH; Cho L; Brennan DM; Hazen SL
Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1383-91. PubMed ID: 19542023
[TBL] [Abstract][Full Text] [Related]
3. Global arginine bioavailability ratio is decreased in patients with major depressive disorder.
Ali-Sisto T; Tolmunen T; Viinamäki H; Mäntyselkä P; Valkonen-Korhonen M; Koivumaa-Honkanen H; Honkalampi K; Ruusunen A; Nandania J; Velagapudi V; Lehto SM
J Affect Disord; 2018 Mar; 229():145-151. PubMed ID: 29310063
[TBL] [Abstract][Full Text] [Related]
4. Elevated levels of plasma symmetric dimethylarginine and increased arginase activity as potential indicators of cardiovascular comorbidity in rheumatoid arthritis.
Chandrasekharan UM; Wang Z; Wu Y; Wilson Tang WH; Hazen SL; Wang S; Elaine Husni M
Arthritis Res Ther; 2018 Jun; 20(1):123. PubMed ID: 29884228
[TBL] [Abstract][Full Text] [Related]
5. Arginine bioavailability ratios are associated with cardiovascular mortality in patients referred to coronary angiography.
Sourij H; Meinitzer A; Pilz S; Grammer TB; Winkelmann BR; Boehm BO; März W
Atherosclerosis; 2011 Sep; 218(1):220-5. PubMed ID: 21632053
[TBL] [Abstract][Full Text] [Related]
6. Global arginine bioavailability, a marker of nitric oxide synthetic capacity, is decreased in PTSD and correlated with symptom severity and markers of inflammation.
Bersani FS; Wolkowitz OM; Lindqvist D; Yehuda R; Flory J; Bierer LM; Makotine I; Abu-Amara D; Coy M; Reus VI; Epel ES; Marmar C; Mellon SH
Brain Behav Immun; 2016 Feb; 52():153-160. PubMed ID: 26515034
[TBL] [Abstract][Full Text] [Related]
7. Multifactorial risk factor intervention in patients with Type 2 diabetes improves arginine bioavailability ratios.
Tripolt NJ; Meinitzer A; Eder M; Wascher TC; Pieber TR; Sourij H
Diabet Med; 2012 Oct; 29(10):e365-8. PubMed ID: 22803961
[TBL] [Abstract][Full Text] [Related]
8. Plasma Arginine/Asymmetric Dimethylarginine Ratio and Incidence of Cardiovascular Events: A Case-Cohort Study.
Yu E; Ruiz-Canela M; Hu FB; Clish CB; Corella D; Salas-Salvadó J; Hruby A; Fitó M; Liang L; Toledo E; Ros E; Estruch R; Gómez-Gracia E; Lapetra J; Arós F; Romaguera D; Serra-Majem L; Guasch-Ferré M; Wang DD; Martínez-González MA
J Clin Endocrinol Metab; 2017 Jun; 102(6):1879-1888. PubMed ID: 28323949
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary hypertension associated with advanced systolic heart failure: dysregulated arginine metabolism and importance of compensatory dimethylarginine dimethylaminohydrolase-1.
Shao Z; Wang Z; Shrestha K; Thakur A; Borowski AG; Sweet W; Thomas JD; Moravec CS; Hazen SL; Tang WH
J Am Coll Cardiol; 2012 Mar; 59(13):1150-8. PubMed ID: 22440215
[TBL] [Abstract][Full Text] [Related]
10. Diminished global arginine bioavailability as a metabolic defect in chronic systolic heart failure.
Tang WH; Shrestha K; Wang Z; Troughton RW; Klein AL; Hazen SL
J Card Fail; 2013 Feb; 19(2):87-93. PubMed ID: 23384633
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide synthetic pathway in red blood cells is impaired in coronary artery disease.
Eligini S; Porro B; Lualdi A; Squellerio I; Veglia F; Chiorino E; Crisci M; Garlaschè A; Giovannardi M; Werba JP; Tremoli E; Cavalca V
PLoS One; 2013; 8(8):e66945. PubMed ID: 23940508
[TBL] [Abstract][Full Text] [Related]
12. Asymmetrical dimethylarginine: a novel risk factor for coronary artery disease.
Lu TM; Ding YA; Charng MJ; Lin SJ
Clin Cardiol; 2003 Oct; 26(10):458-64. PubMed ID: 14579916
[TBL] [Abstract][Full Text] [Related]
13. Intrathecal and systemic alterations of L-arginine metabolism in patients after intracerebral hemorrhage.
Mader MM; Böger R; Appel D; Schwedhelm E; Haddad M; Mohme M; Lamszus K; Westphal M; Czorlich P; Hannemann J
J Cereb Blood Flow Metab; 2021 Aug; 41(8):1964-1977. PubMed ID: 33461409
[TBL] [Abstract][Full Text] [Related]
14. Metabolic profiling of arginine and nitric oxide pathways predicts hemodynamic abnormalities and mortality in patients with cardiogenic shock after acute myocardial infarction.
Nicholls SJ; Wang Z; Koeth R; Levison B; DelFraino B; Dzavik V; Griffith OW; Hathaway D; Panza JA; Nissen SE; Hochman JS; Hazen SL
Circulation; 2007 Nov; 116(20):2315-24. PubMed ID: 17967979
[TBL] [Abstract][Full Text] [Related]
15. The shifted balance of arginine metabolites in acute myocardial infarction patients and its clinical relevance.
Molek P; Zmudzki P; Wlodarczyk A; Nessler J; Zalewski J
Sci Rep; 2021 Jan; 11(1):83. PubMed ID: 33420142
[TBL] [Abstract][Full Text] [Related]
16. Asymmetric dimethylarginine predicts perioperative cardiovascular complications in patients undergoing medium-to-high risk non-cardiac surgery.
Appel D; Böger R; Windolph J; Heinze G; Goetz AE; Hannemann J
J Int Med Res; 2020 Aug; 48(8):300060520940450. PubMed ID: 32842812
[TBL] [Abstract][Full Text] [Related]
17. Levels of asymmetric dimethylarginine in plasma and aqueous humor: a key risk factor for the severity of fibrovascular proliferation in proliferative diabetic retinopathy.
Guo X; Jin W; Xing Y
Front Endocrinol (Lausanne); 2024; 15():1364609. PubMed ID: 38933824
[TBL] [Abstract][Full Text] [Related]
18. Asymmetric dimethylarginine predicts major adverse cardiovascular events in patients with advanced peripheral artery disease.
Mittermayer F; Krzyzanowska K; Exner M; Mlekusch W; Amighi J; Sabeti S; Minar E; Müller M; Wolzt M; Schillinger M
Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2536-40. PubMed ID: 16931791
[TBL] [Abstract][Full Text] [Related]
19. A Low Arginine/Ornithine Ratio is Associated with Long-Term Cardiovascular Mortality.
Ishinoda Y; Masaki N; Hitomi Y; Taruoka A; Kawai A; Iwashita M; Yumita Y; Kagami K; Yasuda R; Ido Y; Toya T; Ikegami Y; Namba T; Nagatomo Y; Miyazaki K; Takase B; Adachi T
J Atheroscler Thromb; 2023 Oct; 30(10):1364-1375. PubMed ID: 36775332
[TBL] [Abstract][Full Text] [Related]
20. Nitric Oxide-Related Biological Pathways in Patients with Major Depression.
Baranyi A; Amouzadeh-Ghadikolai O; Rothenhäusler HB; Theokas S; Robier C; Baranyi M; Koppitz M; Reicht G; Hlade P; Meinitzer A
PLoS One; 2015; 10(11):e0143397. PubMed ID: 26581044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
